Diabetes in French Guiana, adapting national standards of therapeutic education and care to the amazonian challenge.
Nadia Sabbah, Gabriel Carles, Magalie Demar...
https://pubmed.ncbi.nlm.nih.gov/33594330/Actively Recruiting
Led by Admin CIC · Updated on 2026-01-15
78
Participants Needed
2
Research Sites
N/A
Total Duration
Peripheral neuropathies PN affect about 1% of people worldwide, especially older adults, causing problems with walking and chronic pain that reduce quality of life. In French Guiana, researchers think that unknown causes of PN may be linked to exposure to neurotoxic traditional plant remedies, arboviral infections like Zika, Chikungunya, and Dengue, and mercury contamination from illegal gold mining. This study aims to explore how these environmental factors relate to PN, including in people with diabetic neuropathy or chronic idiopathic axonal polyneuropathy. This is a prospective multicenter case-control study conducted at hospitals in Cayenne and Saint-Laurent du Maroni. Participants include patients with diagnosed diabetic peripheral neuropathy or chronic idiopathic axonal polyneuropathy, and a control group of hospital patients without neuropathy. At the initial visit, blood, urine, and hair samples will be collected to test for arbovirus antibodies and measure heavy metals like mercury and lead. Participants will also complete a questionnaire about their use of traditional plants. Participants will not have follow-up visits as part of the study. The main outcome measured is the comparison of exposure rates to these environmental factors between the case and control groups. Additional assessments include identifying genetic mutations and determining peripheral nerve disability at the time of enrollment. The study will help understand environmental risks that might explain unexplained cases of PN in this region.
CONDITIONS
Environmental Factors Associated With Peripheral Neuropathies in French Guiana
N
Nathalie DESCHAMPS, Principal Investigator
V
Vincent De Paul SENEKIAN, Principal Investigator
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Admin CIC
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants provide blood, urine, and hair samples and complete a questionnaire about plant consumption to assess environmental exposures related to peripheral neuropathies.
1 visit (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Nadia Sabbah, Gabriel Carles, Magalie Demar...
https://pubmed.ncbi.nlm.nih.gov/33594330/J Graille, R Blaizot, A S Darrigade...
https://pubmed.ncbi.nlm.nih.gov/31286485/Régine Maury-Brachet, Sophie Gentes, Emilie P Dassié...
https://pubmed.ncbi.nlm.nih.gov/30610584/Mamatha Pasnoor, Osvaldo J M Nascimento, Jaya Trivedi...
https://pubmed.ncbi.nlm.nih.gov/23461611/Laurence Maurice, Fiorella Barraza, Isalyne Blondet...
https://pubmed.ncbi.nlm.nih.gov/33974199/Hartmut H Schmidt, Márcia Waddington-Cruz, Marc F Botteman...
https://pubmed.ncbi.nlm.nih.gov/29211930/Valérie Laperche, Jennifer Hellal, Régine Maury-Brachet...
https://pubmed.ncbi.nlm.nih.gov/25045610/Luíza Morais de Matos, Ariely Teotonio Borges, Aline Barbosa Palmeira...
https://pubmed.ncbi.nlm.nih.gov/35416870/Rens Hanewinckel, Marieke van Oijen, M Arfan Ikram...
https://pubmed.ncbi.nlm.nih.gov/26700499/Admin CIC
Lead Sponsor